Clinical Trial Update: Niraparib in Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of niraparib in pancreatic cancer has completed; the snippet does not include study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED